4 Articles
4 Articles
In addition to a very intense drowsiness during the day, many people with narcolepsy also suffer, among other symptoms, episodes of cataplegia, sudden loss and...
Narcolepsy cannot be treated causally – so far. A new active substance attacks the central disease mechanism for the first time. It seems to help.
Oveporexton reduces sleepiness in people with type 1 of the disease. While the US drug agency approved the product in August, patients hope that it will be the same in Europe.
Oveporexton, a new drug for narcolepsy, is showing promising results in phase 3 studies. The treatment could give new life to affected patients, but it will be some time before the drug becomes available in Sweden.
Coverage Details
Total News Sources4
Leaning Left1Leaning Right2Center0Last Updated67% Right
Bias Distribution
- 67% of the sources lean Right
67% Right
L 33%
R 67%
Factuality
To view factuality data please Upgrade to Premium






